Text Size

A Registry of COPD Patients to be Used for Future Studies

This study is currently recruiting participants.
Verified June 2013 by Ohio State University
Sponsor:
Information provided by (Responsible Party):
Philip Diaz, The Ohio State University
ClinicalTrials.gov Identifier:
NCT00814203
First received: December 23, 2008
Last updated: June 4, 2013
Last verified: June 2013
History of Changes
  Purpose

To develop a cohort of COPD participants to assist study staff in determining the most likely candidates for future studies.


Condition
Chronic Obstructive Lung Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Ohio State University COPD Registry

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Ohio State University:

Primary Outcome Measures:
  • This is a registry protocol to determine factors contributing to the development of chronic obstructive lung disease. [ Time Frame: unknown ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To develop a repository of blood from subjects with COPD for future studies. These studies may include evaluation of biologic markers of disease severity and progression. [ Time Frame: unknown ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

whole blood


Estimated Enrollment: 600
Study Start Date: December 2008
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Chronic obstructive lung disease
those with a condition

Detailed Description:

To develop a cohort of COPD participants for study staff to determine the most likely candidates for future studies and to develop a repository of blood from subjects with COPD for future studies.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic

Criteria

Inclusion Criteria:

  • Patients who are 18 years of age and older who have been diagnosed with COPD by at least one of the following:

    • clinical history-a documented history of COPD, emphysema, or chronic bronchitis;
    • pulmonary function results (defined as an FEV1/FVC less than 0.7;
    • radiographic results (high-resolution CT findings of emphysema

Exclusion Criteria:

  • in ability to give informed consent
  • prisoners
  • pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00814203

Contacts
Contact: Janice E Drake, CRTT 614-366-2287 janice.drake@osumc.edu
Contact: Sharon T Cheung, BS 614-366-2258 sharon.cheung@osumc.edu

Locations
United States, Ohio
The Ohio State University Recruiting
Columbus, Ohio, United States, 43210
Principal Investigator: Philip T Diaz, MD            
Sub-Investigator: Michael E Ezzie, MD            
Sub-Investigator: Clay B Marsh, MD            
Sponsors and Collaborators
Philip Diaz
Investigators
Principal Investigator: Philip Diaz, MD Ohio State University
  More Information

No publications provided

Responsible Party: Philip Diaz, Philip Diaz M.D., The Ohio State University
ClinicalTrials.gov Identifier: NCT00814203     History of Changes
Other Study ID Numbers: 2007H0248
Study First Received: December 23, 2008
Last Updated: June 4, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Ohio State University:
COPD

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on June 13, 2013